ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666159 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666159; 2) Community: the network communities that were significantly associated with the response to NSC 666159; 3) Molecule: the relationships between components within communities and NSC 666159; 4) MDR: the compounds that were significantly associated with the NSC 666159.

NSC Compound Enrichment Correlation
NSC 668333 Null 0.000125296947977996 0.69715252
NSC 668332 Null 0.000601164336889762 0.72567627
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.000931492155975116 0.23701833
NSC 254677 Phomazarin 0.00119931827492064 -0.2204186
NSC 635449 Copper, chloro[2-[1-(2-pyridinyl)ethylidene][N,N-dipropyl-hydrazinecarbothioamidato-N,N,S]- 0.00172842815639262 0.65966075
NSC 636984 Null 0.0018088833864761 0.3241696
NSC 753376 3-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]-1-methyl-1H-indole 0.00180888338647612 0.19699335
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.00181371860170654 0.31244375
NSC 671312 Null 0.00206000157707805 0.48729153
NSC 679095 Null 0.00206000157707805 -0.19738571
Total:50  Current:1    [First] [Prev] [Next] [Last]